pabrolizumab
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for pabrolizumab, covering 2022-07-06 to 2022-07-06. Get the full timeline:
Most recent: Clinical Trial Update: A Prospective, Single-arm Clinical Study of Pabrolizumab in Combination With Cisplatin + 5-FU for the Neoadjuvant Treatment of Unresectable, Advanced Squamous Carcinoma of the Temporal Bone Single-arm Clinical Study [Phase 4]